-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U3amW9xl0lakkLZ3oR4EHVOVosuwNHxNKpfS2PVSfLaKhvOQM36vsPTp8mcufbrT UheCKPevEuT8VKJL+Dmn7Q== 0001024739-98-001161.txt : 19981222 0001024739-98-001161.hdr.sgml : 19981222 ACCESSION NUMBER: 0001024739-98-001161 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981221 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000095676 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 520898764 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-35771 FILM NUMBER: 98772702 BUSINESS ADDRESS: STREET 1: 10240 OLD COLUMBIA RD STREET 2: STE 100 CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 4103096830 MAIL ADDRESS: STREET 1: 10240 OLD COLUMBIA ROAD CITY: COLUMBIA STATE: DE ZIP: 21046- FORMER COMPANY: FORMER CONFORMED NAME: SURVIVAL TECHNOLOGY INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MILLER JAMES H CENTRAL INDEX KEY: 0001027611 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 10240 OLD COLUMBIA RD CITY: COLUMBIA STATE: MD ZIP: 21046 MAIL ADDRESS: STREET 1: C/O MERIDIAN MEDICAL TECHNOLOGIES INC STREET 2: 10240 OLD COLUMBIA RD CITY: COLUMBIA STATE: MD ZIP: 21046 SC 13D 1 SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under The Securities Exchange Act of 1934 (Amendment No. 1)* MERIDIAN MEDICAL TECHNOLOGIES, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.10 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 589658103 - -------------------------------------------------------------------------------- (CUSIP Number) Steven Kaplan, Esq. Arnold & Porter 555 Twelfth Street, N.W. Washington, D.C. 20004-1202 (202) 942-5998 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 20, 1998 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-l(e), 240.13d-l(f) or 240.13d-l(g), check the following box. |_| Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are being sent. *The remainder of this cover shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). This Document Consists of 4 Pages. CUSIP No. 589658103 Schedule 13D Page 4 of 1 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON James H. Miller S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 233,461 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 0 REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 233,461 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 233,461 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.3% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 589658103 Schedule 13D Page 3 of 4 AMENDMENT 15 TO SCHEDULE 13D ---------------------------- The Schedule 13D, dated November 20, 1996, of James H. Miller (the "Reporting Person") is hereby amended as set forth below. The purpose of this Amendment No. 1 to Schedule 13D is to update information regarding James H. Miller's holdings in securities of the issuer as described herein. Except as specifically provided herein, this Amendment No. 1 to Schedule 13D does not modify any of the information previously reported in the Schedule 13D, and should be read in conjunction with, and is qualified in its entirety by reference to, the Schedule 13D. Item 5 is hereby amended as set forth below: Item 5. Interest in Securities of the Issuer (a)-(b) Mr. Miller beneficially owns 233,461 shares of Common Stock, which shares represent approximately 7.3% of the 2,991,080 shares of Common Stock estimated to be outstanding, assuming the exercise by Mr. Miller of options and warrants exercisable within 60 days of December 21, 1998. Of such 233,461 shares of Common Stock, 225,912 shares and 2,857 shares of Common Stock are issuable upon the exercise of options and warrants, respectively. Mr. Miller has the sole power to vote and dispose of the beneficially owned shares of Common Stock. In addition, Mr. Miller holds options covering approximately 107,600 shares of Common Stock that will vest and become exercisable over time in accordance with such options' terms. On November 20, 1998, Mr. Miller transferred 16,654 shares of Common Stock in a private transaction without consideration. CUSIP No. 589658103 Schedule 13D Page 4 of 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 21, 1998 /s/ James H. Miller ----------------- --------------------- (Date) James H. Miller -----END PRIVACY-ENHANCED MESSAGE-----